Analysis of transcription factors determining azole resistance of Aspergillus fumigatus
烟曲霉唑类抗性转录因子分析
基本信息
- 批准号:10451817
- 负责人:
- 金额:$ 50.82万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-08-06 至 2024-07-31
- 项目状态:已结题
- 来源:
- 关键词:ATP-Binding Cassette TransportersAcuteAffectAgricultureAllelesAnabolismAntibioticsAntibodiesAntifungal AgentsAntimicrobial ResistanceAppearanceAspergillosisAspergillus fumigatusAzole resistanceAzolesBinding SitesBiochemicalBiologicalBypassCandidate Disease GeneCarrier ProteinsChIP-seqClinicClinicalCoupledDataDefectDevelopmentDissectionDrug resistanceEnzymesErgosterolGene ExpressionGenesGeneticGenetic EpistasisGenetic ScreeningGenetic TranscriptionGoalsGoldHigh-Throughput DNA SequencingHistidineHumanHyperactivityInfectionLanosterolLeucineLightLinkMammalian CellMedicineMoldsMolecularMutagenesisMutationOrganismParticipantPatientsPharmaceutical PreparationsPhenotypePhysiologicalPhysiologyPredispositionProteinsRegulationResistanceResistance developmentRoleSterol Biosynthesis PathwaySterolsStructureSystemTertiary Protein StructureTestingTranscriptional ActivationVirulenceWorkZinc Clusterantimicrobial drugchemotherapychromatin immunoprecipitationclinically significantexperimental studyfungusgene networkinsightmortalitymutantpathogenic funguspathogenic microbepromoterresistance alleleresistant Aspergillusresistant strainspellingtranscription factortranscriptome sequencing
项目摘要
Invasive Aspergillosis caused by azole resistant A. fumigatus has a mortality rate nearing an alarming 90%, making this a clinical problem of acute significance. Early work on A. fumigatus suggested that azole resistance was rare and that the genetic basis of resistance was most often due to changes in a gene (cyp51A) encoding the azole target protein, lanosterol α-14 demethylase. Recent work from our groups has provided evidence that expression of an ATP-binding cassette (ABC) transporter-encoding gene called abcG1 (aka cdr1B) is linked to azole resistance in the absence of any changes at the cyp51A locus. Here we propose to investigate a key transcriptional regulator called AtrR that coordinately regulates expression of both cyp51A and abcG1. AtrR is a Zn2Cys6 zinc cluster-containing factor that resembles other fungal transcriptional regulators of drug resistance. We have found that loss of the atrR gene eliminated the high-level azole resistance seen in clinical isolates. Additional, preliminary data generated by use of chromatin immunoprecipitation coupled with high throughput DNA sequencing (ChIP-seq) and RNA-seq have shed light on direct and indirect targets of AtrR regulation. We have generated two different hyperactive alleles of atrR that drive elevated expression of abcG1 and enhanced azole resistance. These data suggest that AtrR is normally subject to negative regulation that can be overcome in different manners. We suggest that defects in this negative regulatory system may influence clinically significant azole resistance owing to increased expression of AtrR-dependent target genes (like abcG1 and cyp51A). The goal of this proposal is to employ a combined biochemical, molecular biological and genetic dissection of the regulation of AtrR in order to understand how this factor acts to induce azole resistance. Our initial goal is to carry out a structure/function analysis of AtrR and identify protein domains that are important for regulation of this factor. We will also use direct biochemical purification to identify factors that associate with AtrR and influence its function. Second, we will use forward genetic screening involving impala transposon mutagenesis to identify AtrR regulatory factors in an unbiased, functional manner. Finally, we will examine the role of an AtrR target gene that encodes a transcription factor called RfeC. Preliminary data indicate that RfeC is important in AbcG1 expression and azole resistance. We will examine the epistatic relationship between our atrR alleles and rfeC (as well as other azole resistance-affecting transcription factors) to establish the regulatory hierarchy controlling azole resistance. These experiments will illuminate the physiological network controlling AtrR that directly links ergosterol biosynthesis to ABC transporter gene expression and provide important new information about azole resistance in this fungal pathogen.
耐唑A.烟曲霉的死亡率接近惊人的90%,使其成为具有严重意义的临床问题。早期的工作A。烟曲霉的研究表明,唑类耐药性是罕见的,抗性的遗传基础最常见的是由于编码唑类靶蛋白--羊毛甾醇α-14去甲基酶的基因(cyp 51 A)的变化。我们小组最近的工作提供了证据表明,在cyp 51 A位点没有任何变化的情况下,ATP结合盒(ABC)转运蛋白编码基因abcG 1(又名cdr 1B)的表达与唑类耐药有关。在这里,我们建议调查一个关键的转录调节称为AtrR,协调调节cyp 51 A和abcG 1的表达。AtrR是一个含锌2Cys 6锌簇的因子,类似于其他真菌耐药性的转录调节因子。我们发现,atrR基因的缺失消除了临床分离株中观察到的高水平唑类耐药。此外,通过使用染色质免疫沉淀结合高通量DNA测序(ChIP-seq)和RNA-seq产生的初步数据揭示了AtrR调控的直接和间接靶标。我们已经产生了两种不同的atrR过度活跃的等位基因,驱动abcG 1的表达升高和唑类耐药性增强。这些数据表明,AtrR通常受到可以以不同方式克服的负调控。我们认为,在这个负调控系统的缺陷可能会影响临床显着的唑类药物耐药,由于AtrR依赖的靶基因(如abcG 1和cyp 51 A)的表达增加。本提案的目标是采用生物化学,分子生物学和遗传学相结合的解剖AtrR的调节,以了解该因子如何诱导唑类耐药。我们的初步目标是进行AtrR的结构/功能分析,并确定蛋白质结构域,这是重要的调节这个因素。我们还将使用直接生化纯化来鉴定与AtrR相关并影响其功能的因子。其次,我们将使用正向遗传筛选涉及黑斑羚转座子诱变,以确定AtrR的调节因子在一个公正的,功能性的方式。最后,我们将研究编码转录因子RfeC的AtrR靶基因的作用。初步数据表明RfeC在AbcG 1表达和唑类耐药性中是重要的。我们将研究我们的atrR等位基因和rfeC(以及其他唑类耐药影响转录因子)之间的上位性关系,以建立控制唑类耐药的调控层次。这些实验将阐明控制AtrR的生理网络,直接将麦角甾醇生物合成与ABC转运蛋白基因表达联系起来,并提供有关这种真菌病原体中唑类抗性的重要新信息。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
W Scott Moye-Rowley其他文献
W Scott Moye-Rowley的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('W Scott Moye-Rowley', 18)}}的其他基金
Chemical genetic analysis of Candida glabrata CDR1 expression
光滑念珠菌CDR1表达的化学遗传分析
- 批准号:
10588383 - 财政年份:2022
- 资助金额:
$ 50.82万 - 项目类别:
Identification of virulence determinants under the transcriptional control of AtrR in Aspergillus fumigatus
烟曲霉 AtrR 转录控制下毒力决定簇的鉴定
- 批准号:
10088398 - 财政年份:2020
- 资助金额:
$ 50.82万 - 项目类别:
Identification of virulence determinants under the transcriptional control of AtrR in Aspergillus fumigatus
烟曲霉 AtrR 转录控制下毒力决定簇的鉴定
- 批准号:
9914775 - 财政年份:2020
- 资助金额:
$ 50.82万 - 项目类别:
Analysis of transcription factors determining azole resistance of Aspergillus fumigatus
烟曲霉唑类抗性转录因子分析
- 批准号:
10664888 - 财政年份:2019
- 资助金额:
$ 50.82万 - 项目类别:
Analysis of transcription factors determining azole resistance of Aspergillus fumigatus
烟曲霉唑类抗性转录因子分析
- 批准号:
10207376 - 财政年份:2019
- 资助金额:
$ 50.82万 - 项目类别:
A new pathway for azole resistance in Aspergillus fumigatus
烟曲霉唑类抗性的新途径
- 批准号:
8972533 - 财政年份:2015
- 资助金额:
$ 50.82万 - 项目类别:
A new pathway for azole resistance in Aspergillus fumigatus
烟曲霉唑类抗性的新途径
- 批准号:
9089985 - 财政年份:2015
- 资助金额:
$ 50.82万 - 项目类别:
Role of transcriptional regulation in Aspergillus fumigatus drug resistance
转录调控在烟曲霉耐药性中的作用
- 批准号:
8191041 - 财政年份:2011
- 资助金额:
$ 50.82万 - 项目类别:
Role of transcriptional regulation in Aspergillus fumigatus drug resistance
转录调控在烟曲霉耐药性中的作用
- 批准号:
8264953 - 财政年份:2011
- 资助金额:
$ 50.82万 - 项目类别:
Regulation of eukaryotic membrane structure and function
真核细胞膜结构和功能的调节
- 批准号:
8033388 - 财政年份:2010
- 资助金额:
$ 50.82万 - 项目类别:
相似海外基金
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 50.82万 - 项目类别:
Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 50.82万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 50.82万 - 项目类别:
Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 50.82万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 50.82万 - 项目类别:
Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 50.82万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 50.82万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 50.82万 - 项目类别:
Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 50.82万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
- 批准号:
2244994 - 财政年份:2023
- 资助金额:
$ 50.82万 - 项目类别:
Standard Grant